Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2000, p. 1970-1973, Vol. 44, No. 7
Departament de Microbiologia, Hospital de la
Santa Creu i Sant Pau, Universitat Autònoma 08025 Barcelona,1 and Departament de
Genètica i Microbiologia, Universitat Autònoma de
Barcelona, 08193 Bellaterra,2 Spain
Received 21 October 1999/Returned for modification 20 February
2000/Accepted 30 March 2000
A new CTX-M-type Not long after the beginning of the
use of the extended-spectrum In 1996, a cefotaxime-resistant Escherichia coli strain
(785-D) against which synergy of cefotaxime with clavulanic acid was found was detected by a conventional disk diffusion susceptibility test. The strain was isolated from the urine of a 65-year-old woman who
had a urinary tract infection and diabetes mellitus type 2. Two months
before the isolation, the patient underwent a nephroureterectomy
because of a renal carcinoma.
The MICs of the Substrate hydrolysis in sonic extracts was monitored
spectrophotometrically with a Biochrom 4060 spectrophotometer
(Pharmacia, Uppsala, Sweden) as described previously (19).
Conjugation studies were performed in a solid medium as described
previously (19) by using E. coli 785-D
(susceptible to kanamycin) and E. coli HB101
(Nalr Kanr) as the donor and the recipient,
respectively. Kanamycin (50 µg/ml) and cefotaxime (4 µg/ml) were
used for transconjugant selection. One of the transconjugants (E. coli MSP492) was used for further experiments.
Extraction of plasmid DNA was by the alkaline lysis procedure reported
previously (18). Cloning of the cefotaxime resistance gene
was as follows: plasmid DNA from E. coli MSP492 was
partially digested with Sau3AI, and the resultant fragments
(size range, 2 to 4 kb) were ligated into the BamHI site of
the pK184 vector (16). Afterward, E. coli DH5 Isoelectric focusing analysis showed that the wild-type E. coli strain (strain 785-D) expressed two The
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cloning and Sequence of the Gene Encoding a Novel
Cefotaxime-Hydrolyzing
-Lactamase (CTX-M-9) from
Escherichia coli in Spain
![]()
ABSTRACT
Top
Abstract
Text
References
-lactamase (CTX-M-9) has been cloned from a
clinical cefotaxime-resistant Escherichia coli strain.
Despite the close identity that exists between the CTX-M-9 and Toho-2
-lactamases (88%), the 35 amino acids located between residues Ala-185 and Ala-219 are totally different in both enzymes. Outside of
this region there are only six amino acids substitutions between both proteins.
![]()
TEXT
Top
Abstract
Text
References
-lactam antibiotics, extended-spectrum
-lactamases (ESBLs) were detected in Europe and the United States
and have now become a serious problem around the world. ESBLs are most
often derivatives of TEM or SHV enzymes. However, there is a small
growing family of plasmid-mediated ESBLs of Ambler class A that are not
closely related to TEM or SHV
-lactamases but that show homology to
chromosomal
-lactamases of Klebsiella oxytoca, including
CTX-M-1 (MEN-1) (3, 5-7), CTX-M-2 (4, 6),
CTX-M-3 (14), CTX-M-4 (12, 13), CTX-M-6 (11,
20), Toho-1 (15), Toho-2 (17), and two
different enzymes, both designated CTX-M-5, which will be referred to
here as CTX-M-5 (8) and CTX-M-7 (11, 20). In this
report we present a new
-lactamase closely related to the
-lactamases in this family.
-lactam antibiotics were determined by the Etest
(Biodisk, Solna, Sweden). The
-lactamase crude cell extracts were
prepared from 250-ml cultures in Luria-Bertani (LB) broth (Oxoid,
Basingstoke, United Kingdom). Washed, centrifuged cell pellets were
subjected to three cycles of 15-s sonication treatments at 4°C, and
the supernatants of the sonic extracts were frozen at
20°C until
they were tested.
-Lactamases were characterized initially by
isoelectric focusing as described previously (2) in
polyacrylamide gels with a pH gradient from 4 to 11 (SERVALYT 4-9 T,
9-11 T; Serva, Heidelberg, Germany). Enzyme activities in the gel were
detected by the iodometric method (2).
was transformed with the ligation mixture, and cefotaxime-resistant
colonies were selected on LB agar plates supplemented with 4 µg of
cefotaxime per ml. One of these E. coli DH5
transformants
(MSP493) that contained plasmid pK184, which carries a 2-kb
Sau3AI fragment (pMSP072), was selected for further studies.
DNA sequencing was carried out by the dideoxy method (9)
with fluorescent primers and the Automatic Laser Fluorescent DNA
Sequencer (ALF; Pharmacia). The entire nucleotide sequence was
determined on both DNA strands.
-lactamases with pIs of 5.4 and about 8.0, respectively. Moreover, E. coli MSP492
and E. coli MSP493 strains expressed only a
-lactamase
with a pI of about 8.0.
-lactam susceptibility profiles of the parental E. coli strain (strain 785-D), the two reference strains (E. coli DH5
and E. coli HB101), and strains E. coli MSP492 and E. coli MSP493 are presented in Table
1. All strains that contained the
-lactamase with a pI of about 8.0 (strains 785-D, MSP492, and
MSP493) have similar susceptibility patterns. The level of resistance
to
-lactams of all of the strains was similar to that observed for
other strains of the family Enterobacteriaceae that produce
CTX-M-type
-lactamases (3-8, 11-15, 17, 20, 21). Thus,
these three strains were resistant to all penicillins and
cephalosporins tested except cefoxitin, ceftazidime, and aztreonam
(Table 1). Furthermore, the activities of penicillins, cefotaxime, and
ceftazidime were restored in the presence of inhibitors.
TABLE 1.
MICs of
-lactams for reference and
CTX-M-9-producing strains
Kinetic parameters for the
-lactamase enzyme with a pI of about 8.0 obtained from the transconjugant strain (strain MSP492) are presented
in Table 2. The antibiotic against which
it had the greatest activity (relative Vmax),
cefotaxime, as well as the inhibitory activities (50% inhibitory
concentrations [IC50s]) of
-lactamase inhibitors are
similar to those described for the CTX-M-type
-lactamases
(3-8, 11-15, 17, 20, 21). Likewise, this enzyme was
inhibited by low concentrations of tazobactam (IC50, 1 nM),
while inhibition by clavulanate and sulbactam required higher
concentrations (IC50s, 10 and 700 nM, respectively).
|
After confirming by isoelectric focusing that E. coli cells
that carry the pMSP072 plasmid harbor the same
-lactamase harbored by the E. coli 785-D and MSP492 strains, the nucleotide
sequence of the 2-kb fragment cloned in this plasmid was determined.
Analysis of this sequence shows an 873-nucleotide open reading frame
that presents a close homology with those of CTX-M-type enzymes. The alignment of the deduced 291-amino-acid sequence of this open reading
frame with other
-lactamases is shown in Fig.
1. On the basis of its similarity with
previously characterized CTX-M-type
-lactamases, the most likely
signal peptide would consist of 29 amino acids residues (11,
12), whereas the mature
-lactamase could comprise 262 amino
acids. The consensus sequences 70SXXK73,
130SDN132, E166, and
234KTG236 (numbering of Ambler et al.
[1]) typical of class A serine
-lactamases were
also found in the amino acid sequence of this new
-lactamase (Fig.
1). The degree of amino acid sequence homology of the mature protein
with other plasmid-mediated CTX-M-type
-lactamases was higher than
80% (Table 3). In agreement with all of
these data, we have designated this
-lactamase CTX-M-9. However, the N- and C-terminal sequences of the CTX-M-9 protein are dramatically different from the sequences of the same regions of other CTX-M-type
-lactamases except Toho-2 (Fig. 1).
|
|
The CTX-M-9 mature protein presents an 88% sequence homology with
Toho-2, although the 35 amino acids located between Ala-185 and Ala-219
are completely different (Fig. 1). Compared with the other CTX-M
enzymes, there are only four or five amino acid substitutions within
this 35-amino-acid region. This difference between Toho-2 and the
CTX-M-type enzymes, including CTX-M-9, is due to three sets of
nucleotide deletions in Toho-2 at positions 564 and 565 (GA), 585 and
586 (GC), and 622 (G) with respect to the CTX-M-9 translational
starting point, which change the reading frame. However, a fourth
deletion (a G at position 659) recovers the initial reading frame.
Outside of this region there are only six amino acid substitutions
between CTX-M-9 and Toho-2 proteins. Moreover, all characteristic
substitutions assumed to be implicated in cephalosporin hydrolysis
(Cys-69, Ala-205, Ser-237, Thr-244, and Arg-276) (11, 12,
17) in the CTX-M-type
-lactamases are also present in CTX-M-9.
Regardless of the comparison of the amino acid sequence that suggests
that CTX-M-9 and the other CTX-M-type
-lactamases are closely
related, the amino acid sequence differences between them (about 15%)
are too many for CTX-M-9 to be considered a direct descendant of any of
the others. Otherwise, the analysis of amino acid sequences of several
-lactamases suggests a close relationship of plasmid-mediated
CTX-M-type enzymes with the chromosomal
-lactamases of
Klebsiella oxytoca, Citrobacter diversus, and
Proteus vulgaris (6, 10), but there is no evident
phylogenetic connection between the CTX-M-type
-lactamases and other
bla genes.
From 1996 to 1998, 23 strains (22 E. coli strains and 1 Salmonella enterica serotype Virchow strain) that presented
the same resistance phenotype and that carried a
-lactamase with a
pI of about 8.0 have been sporadically detected in our laboratory. All
of these isolated strains were PCR positive when two primers selected
from the blaCTX-M-9 nucleotide sequence (5'-GTG
ACA AAG AGA GTG CAA CGG-3' and 5'-ATG ATT CTC GCC GCT GAA GCC-3', which comprise positions 4 to 24 and 860 to 840, respectively, with respect
to its translational starting point) were used (data not shown). These
results suggest that the CTX-M-9
-lactamase is synthesized in all of them.
CTX-M-type
-lactamase-producing strains have been incidentally
identified for 10 years as single or epidemic clinical isolates in very
distant geographic regions: CTX-M-1 in Germany in 1989 (5),
MEN-1 in France from a patient from Italy in 1989 (3, 7),
CTX-M-2 in Argentina in 1990 (4), CTX-M-3 in Poland in 1996 (14), CTX-M-4 in Russia in 1996 (12, 13), CTX-M-5 in Latvia in 1991 (8), CTX-M-7 in Greece in 1996 (11,
20), CTX-M-6 in Greece in 1997 (11, 20), and Toho-1 in
1993 and Toho-2 in 1995 in Japan (15, 17). In addition to
these initial findings, the presence of the CTX-M-type
-lactamases
has been described in various species of the family
Enterobacteriaceae in widely distant geographic areas, with
all them being plasmid encoded. The present work is the first report of
a CTX-M-type
-lactamase in Spain. In our laboratory CTX-M-9 is,
although rare, the most frequent ESBL detected. The divergence of the
amino acid sequences as well as the temporal and geographic dispersion
of strains that carry this
-lactamase makes any assumption about the
origin of this plasmid-mediated
-lactamase difficult. These facts
raise important questions about whether such enzymes arise de novo in
multiple geographic locations or, alternatively, are disseminated
around the world.
Nucleotide sequence accession number. The accession number of the nucleotide sequence of the blaCTX-M-9 gene in the GenBank database is AF174129.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to B. Mirelis for helpful advice and comments. We thank the "Fundación Ma Francisca de Roviralta" for financial support. We are deeply indebted to Joan Ruiz and M. Mar López for excellent technical assistance.
This work was supported partially by grants FIS 97/0623 and FIS 98/1522 to G.P.; J.B. was supported by grants PB97-0194 and BIO99-0779 from the Ministerio de Educación y Ciencia of Spain and 1999SGR-00106 from the Comissionat per Universitats i Recerca de la Generalitat de Catalunya.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Departament de Microbiologia, Hospital de la Santa Creu i Sant Pau, Av. Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain. Phone: 34 93 2919071. Fax: 34 93 2919070. E-mail: fnavarror{at}hsp.santpau.es.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ambler, R. P.,
A. F. W. Coulson,
J. M. Frere,
J. M. Ghuysen,
B. Joris,
M. Forsman,
R. C. Levesque,
G. Tiraby, and S. G. Waley.
1991.
A standard numbering scheme for the class A -lactamases.
Biochem. J.
276:269-270.
|
| 2. |
Barthélémy, M.,
M. Guionie, and R. Labia.
1979.
-Lactamases: determination of their isoelectric points.
Antimicrob. Agents Chemother.
13:695-698.
|
| 3. |
Barthélémy, M.,
J. Peduzzi,
H. Bernard,
C. Tancrède, and R. Labia.
1992.
Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum -lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca.
Biochim. Biophys. Acta
1122:15-22[CrossRef][Medline].
|
| 4. | Bauernfeind, A., J. M. Casellas, M. Goldberg, M. Holley, R. Jungwirth, P. Mangold, T. Röhnisch, S. Schweighart, and R. Wilhelm. 1992. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20:158-163[CrossRef][Medline]. |
| 5. | Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298[CrossRef][Medline]. |
| 6. |
Bauernfeind, A.,
I. Stemplinger,
R. Jungwirth,
S. Ernst, and J. M. Casellas.
1996.
Sequence of -lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other -lactamases.
Antimicrob. Agents Chemother.
40:509-513[Abstract].
|
| 7. |
Bernard, H.,
C. Tancrede,
V. Livrelli,
A. Morand,
M. Barthélémy, and R. Labia.
1992.
A novel plasmid-mediated extended-spectrum -lactamase not derived from TEM- or SHV-type enzymes.
J. Antimicrob. Chemother.
29:590-592 |
| 8. |
Bradford, P. A.,
Y. Yang,
D. Sahm,
I. Grope,
D. Gardovska, and G. Storch.
1998.
CTX-M-5, a novel cefotaxime-hydrolyzing -lactamase from an outbreak of Salmonella typhimurium in Latvia.
Antimicrob. Agents Chemother.
42:1980-1984 |
| 9. | Fernandez de Henestrosa, A. R., E. Rivera, A. Tapias, and J. Barbé. 1998. Identification of the Rhodobacter sphaeroides SOS box. Mol. Microbiol. 28:991-1003[CrossRef][Medline]. |
| 10. |
Fournier, B.,
P. H. Roy,
P. H. Lagrange, and A. Philippon.
1996.
Chromosomal -lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.
Antimicrob. Agents Chemother.
40:454-459[Abstract].
|
| 11. |
Gazouli, M.,
E. Tzelepi,
A. Markogiannakis,
N. J. Legakis, and L. S. Tzouvelekis.
1998.
Two novel plasmid-mediated cefotaxime-hydrolyzing -lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium.
FEMS Microbiol. Lett.
165:289-293[Medline].
|
| 12. |
Gazouli, M.,
E. Tzelepi,
S. V. Sidorenko, and L. S. Tzouvelekis.
1998.
Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A -lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis.
Antimicrob. Agents Chemother.
42:1259-1262 |
| 13. |
Gazouli, M.,
S. V. Sidorenko,
E. Tzelepi,
N. S. Kozlova,
D. P. Gladin, and L. S. Tzouvelekis.
1998.
A plasmid-mediated -lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia.
J. Antimicrob. Chemother.
41:119-121 |
| 14. |
Gniadkowski, M.,
I. Schneider,
A. Palucha,
R. Jungwirth,
B. Mikiewicz, and A. Bauernfeind.
1998.
Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing -lactamase that is closely related to the CTX-M-1/MEN-1 enzyme.
Antimicrob. Agents Chemother.
42:827-832 |
| 15. |
Ishii, Y.,
A. Ohno,
H. Taguchi,
S. Imajo,
M. Ishiguro, and H. Matsuzawa.
1995.
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A -lactamase isolated from Escherichia coli.
Antimicrob. Agents Chemother.
39:2269-2275[Abstract].
|
| 16. |
Jobbling, M. G., and R. K. Holmes.
1990.
Construction of vectors with the p15a replicon, kanamycin resistance, inducible lacZ and pUC18 or pUC19 multiple cloning sites.
Nucleic Acids Res.
18:5315-5316 |
| 17. |
Ma, L.,
Y. Ishii,
M. Ishiguro,
H. Matsuzawa, and K. Yamaguchi.
1998.
Cloning and sequencing of the gene encoding Toho-2, a class A -lactamase preferentially inhibited by tazobactam.
Antimicrob. Agents Chemother.
42:1181-1186 |
| 18. | Miller, J. M. 1992. A short course in bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 19. |
Miró, E.,
M. del Cuerpo,
F. Navarro,
M. Sabaté,
B. Mirelis, and G. Prats.
1998.
Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.
J. Antimicrob. Chemother.
42:535-538 |
| 20. |
Tzouvelekis, L. S.,
M. Gazouli,
A. Markogiannakis,
E. Paraskaki,
N. J. Legakis, and E. Tzelepi.
1998.
Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases.
J. Antimicrob. Chemother.
42:273-275 |
| 21. |
Yagi, T.,
H. Kurokawa,
K. Senda,
S. Ichiyama,
H. Ito,
S. Ohsuka,
K. Shibayama,
K. Shimokata,
N. Kato,
M. Ohta, and Y. Arakawa.
1997.
Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like -lactamase genes.
Antimicrob. Agents Chemother.
41:2606-2611[Abstract].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»